The data submission period has ended.
We would like to thank every doctor & surgeon who participated in our study. Your contribution is invaluable to us & every patient counts. We wouldn't have reached this point without you all.
Now the hard work begins @T4UGIS@tugs_audits
Counting Down, 3⃣ days left till the end of our study. Make sure you submit your data by 15/08. Any data submitted after the deadline will not be accepted.
Your collaboration is invaluable to us and to our study. Thank you all.
#hernia#herniatrials@T4UGIS@tugs_audits
Big thanks to all the collaborators. We have started receiving data for the AROMA Study.
Every patient counts and your contribution is invaluable to us and to our study.
Remember last day for data submission is 15/08.
@T4UGIS@tugs_audits#herniatrials#hernia#surgery
Today marks the last day in the study's inclusion period.
7️⃣0️⃣0️⃣ Registration from >6️⃣0️⃣ countries.
Thanks to all the collaborators
Now starts the hard work.
@T4UGIS@tugs_audits
1️⃣ month left till the end of our study. Hope data collection is running smoothly and you are following the patients as required.
We aspire to get the largest number of patients from all around the world and we can't do that without your help. @tugs_audits@T4UGIS
Cases of Strangulated Hernia, Treated by Inflation of the Bowels, and by Shaking the Patient Whilst in an Inverted Position,Published in 1864
Interesting approach 🤓🤔
Good we stopped doing that, i'm not strong enough to invert and shake the patient 😂😂
https://t.co/ekq8PT99iy
Hernia Surgeons - We need you! Join us for this international collaborative project - GENESIS Study to understand patient reported outcome measures following Inguinal hernia repair.
To register: [email protected]
Dear doctors:
Do not miss the opportunity to participate in one of the biggest collaborative studies on esophageal elective cancer surgery. Although the Outlive study started three weeks ago, you are still on time to participate.
https://t.co/Q2FEQQLtiX
We are almost 300 collaborators! This is a huge milestone!
We need your help to make this study even bigger!
Share it through your network! Bear in mind that increasing the number of collaborators will also increase the likelihood of publishing this study in a high IF journal.
The OUTLIVE study will start today !
Do not miss the opportunity to participate in one of the biggest collaborative studies on esophageal elective cancer surgery.
You can participate by clicking on this link: https://t.co/Q2FEQQLtiX
The Outlive study will start on the 1st of April 2022!
If your field of interest is Esophageal cancer surgery, do not hesitate to join one of the biggest audits in the field. There are already 266 collaborators.
You can register through this link: https://t.co/Q2FEQQLtiX